DK1256581T3 - Forebyggende eller terapeutiske midler til gastrisk eller ösofageal regurgitation - Google Patents
Forebyggende eller terapeutiske midler til gastrisk eller ösofageal regurgitationInfo
- Publication number
- DK1256581T3 DK1256581T3 DK01902793T DK01902793T DK1256581T3 DK 1256581 T3 DK1256581 T3 DK 1256581T3 DK 01902793 T DK01902793 T DK 01902793T DK 01902793 T DK01902793 T DK 01902793T DK 1256581 T3 DK1256581 T3 DK 1256581T3
- Authority
- DK
- Denmark
- Prior art keywords
- group
- preventive
- oesophageal
- regurgitation
- gastric
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 230000003449 preventive effect Effects 0.000 title abstract 2
- 206010067171 Regurgitation Diseases 0.000 title 1
- 230000002496 gastric effect Effects 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
- 230000000694 effects Effects 0.000 abstract 2
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 230000009858 acid secretion Effects 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4743—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000031542 | 2000-02-09 | ||
| PCT/JP2001/000852 WO2001058898A1 (en) | 2000-02-09 | 2001-02-07 | Preventive or therapeutic agents for gastric or esophageal regurgitation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1256581T3 true DK1256581T3 (da) | 2007-09-24 |
Family
ID=18556282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01902793T DK1256581T3 (da) | 2000-02-09 | 2001-02-07 | Forebyggende eller terapeutiske midler til gastrisk eller ösofageal regurgitation |
Country Status (13)
| Country | Link |
|---|---|
| US (7) | US6967207B2 (da) |
| EP (1) | EP1256581B1 (da) |
| JP (1) | JP4781592B2 (da) |
| KR (1) | KR100750437B1 (da) |
| AT (1) | ATE358128T1 (da) |
| AU (1) | AU2001230588A1 (da) |
| CA (1) | CA2399818C (da) |
| DE (1) | DE60127535T2 (da) |
| DK (1) | DK1256581T3 (da) |
| ES (1) | ES2284612T3 (da) |
| PT (1) | PT1256581E (da) |
| TW (1) | TWI256314B (da) |
| WO (1) | WO2001058898A1 (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI256314B (en) * | 2000-02-09 | 2006-06-11 | Mitsubishi Pharma Corp | Preventive-therapeutical medicament for gastroesophageal reflux disease |
| DE60231017D1 (de) | 2001-08-24 | 2009-03-12 | Mitsubishi Tanabe Pharma Corp | Mittel zur Prävention und Behandlung des vorwiegend durch Obstipation geprägten Reizdarms |
| WO2003020728A1 (en) | 2001-08-30 | 2003-03-13 | Pharmacia & Upjohn Company | 4-THIOXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOTHIOAMIDES AS ANTIVIRAL AGENTS |
| CZ2004408A3 (cs) * | 2001-10-02 | 2005-03-16 | Pharmacia & Upjohn Company | Azabicyklicky substituované kondenzované heteroarylsloučeniny |
| AR038118A1 (es) | 2002-01-14 | 2004-12-29 | Upjohn Co | Compuestos derivados de la bencinamida del acido 7-oxo-4,7-dihidrotien[2,3-b[piridin-6-carboxilico 3-sustituido que son utiles como antivirales |
| AR038117A1 (es) | 2002-01-14 | 2004-12-29 | Upjohn Co | Agentes antivirales derivados de la 4- oxo-4,7 -dihidrofuro [2,3-b]piridin-5-carboxamida |
| AR038294A1 (es) | 2002-01-14 | 2005-01-12 | Upjohn Co | Oxotieno(3,2-b)piridincarboxamidas como agentes antivirales |
| CA2537182A1 (en) * | 2003-08-29 | 2005-03-10 | Dynogen Pharmaceuticals, Inc. | Compositions useful for treating gastrointestinal motility disorders |
| US8642067B2 (en) | 2007-04-02 | 2014-02-04 | Allergen, Inc. | Methods and compositions for intraocular administration to treat ocular conditions |
| AU2008262438A1 (en) * | 2007-06-07 | 2008-12-18 | Dynogen Pharmaceuticals, Inc. | Compositions useful for treating gastroesophageal reflux disease |
| CA2767233A1 (en) * | 2009-07-14 | 2011-01-20 | Albany Molecular Research, Inc. | 5-ht3 receptor modulators, methods of making, and use thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4829073A (en) * | 1988-05-12 | 1989-05-09 | Bristol-Myers Company | Thiadiazole oxides for treating gastrointestinal motility disorders |
| EP0423777A3 (en) * | 1989-10-19 | 1991-09-25 | G.D. Searle & Co. | Method of treating gastrointestinal motility disorders |
| JP2699794B2 (ja) * | 1992-03-12 | 1998-01-19 | 三菱化学株式会社 | チエノ〔３，２−ｂ〕ピリジン誘導体 |
| SE9603408D0 (sv) * | 1996-09-18 | 1996-09-18 | Astra Ab | Medical use |
| TWI256314B (en) * | 2000-02-09 | 2006-06-11 | Mitsubishi Pharma Corp | Preventive-therapeutical medicament for gastroesophageal reflux disease |
-
2001
- 2001-02-05 TW TW090102372A patent/TWI256314B/zh not_active IP Right Cessation
- 2001-02-07 US US10/203,278 patent/US6967207B2/en not_active Expired - Fee Related
- 2001-02-07 DE DE60127535T patent/DE60127535T2/de not_active Expired - Lifetime
- 2001-02-07 DK DK01902793T patent/DK1256581T3/da active
- 2001-02-07 ES ES01902793T patent/ES2284612T3/es not_active Expired - Lifetime
- 2001-02-07 AT AT01902793T patent/ATE358128T1/de not_active IP Right Cessation
- 2001-02-07 KR KR1020027010059A patent/KR100750437B1/ko not_active Expired - Fee Related
- 2001-02-07 CA CA002399818A patent/CA2399818C/en not_active Expired - Fee Related
- 2001-02-07 EP EP01902793A patent/EP1256581B1/en not_active Expired - Lifetime
- 2001-02-07 AU AU2001230588A patent/AU2001230588A1/en not_active Abandoned
- 2001-02-07 WO PCT/JP2001/000852 patent/WO2001058898A1/ja not_active Ceased
- 2001-02-07 JP JP2001558448A patent/JP4781592B2/ja not_active Expired - Fee Related
- 2001-02-07 PT PT01902793T patent/PT1256581E/pt unknown
-
2005
- 2005-08-31 US US11/214,818 patent/US20050282852A1/en not_active Abandoned
-
2006
- 2006-08-21 US US11/507,010 patent/US20060281781A1/en not_active Abandoned
-
2008
- 2008-07-29 US US12/219,806 patent/US20080293762A1/en not_active Abandoned
-
2009
- 2009-09-22 US US12/564,650 patent/US20100168157A1/en not_active Abandoned
- 2009-09-23 US US12/565,261 patent/US20100210679A1/en not_active Abandoned
- 2009-10-09 US US12/588,307 patent/US20100204267A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20100204267A1 (en) | 2010-08-12 |
| US20100210679A1 (en) | 2010-08-19 |
| DE60127535T2 (de) | 2007-12-06 |
| EP1256581A4 (en) | 2004-10-06 |
| TWI256314B (en) | 2006-06-11 |
| CA2399818C (en) | 2010-01-12 |
| WO2001058898A1 (en) | 2001-08-16 |
| US20030130304A1 (en) | 2003-07-10 |
| US6967207B2 (en) | 2005-11-22 |
| CA2399818A1 (en) | 2001-08-16 |
| ES2284612T3 (es) | 2007-11-16 |
| JP4781592B2 (ja) | 2011-09-28 |
| DE60127535D1 (de) | 2007-05-10 |
| KR100750437B1 (ko) | 2007-08-21 |
| EP1256581B1 (en) | 2007-03-28 |
| AU2001230588A1 (en) | 2001-08-20 |
| ATE358128T1 (de) | 2007-04-15 |
| KR20020089340A (ko) | 2002-11-29 |
| PT1256581E (pt) | 2007-06-26 |
| US20100168157A1 (en) | 2010-07-01 |
| US20060281781A1 (en) | 2006-12-14 |
| EP1256581A1 (en) | 2002-11-13 |
| US20050282852A1 (en) | 2005-12-22 |
| US20080293762A1 (en) | 2008-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20020968L (no) | Glukopyranosyloksypyrazolderivater, medisinske sammensetninger inneholdende det samme og intermediater forfremstillingen derav | |
| IL205420A (en) | Immunogoldular and Derivative Compounds, Pharmaceutical Compounds in the Treatment of Inflammatory Stomach and Gastrointestinal Disorders | |
| CY1111951T1 (el) | Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου | |
| NO20071042L (no) | 5-substituerte 2-fenylaminobenzamider som MEK-inhibitorer | |
| FI943948A0 (fi) | Heterosykliset hiilihappojohdannaiset | |
| SE0104332D0 (sv) | Therapeutic agents | |
| DK1065204T3 (da) | Bicykliske carbonyl-indolforbindelser som anti-inflammatoriske/analgesiske midler og som COX-2-inhibitorer | |
| TR200302242T2 (tr) | Protein kinaz önleyicileri olarak pirolopirimidinler | |
| JP2004507521A5 (da) | ||
| EA200501703A1 (ru) | Применение производных азетидинкарбоксамида в терапии | |
| MXPA02002452A (es) | Agentes preventivos y terapeuticos para enfermedades de oftalmicas. | |
| DE60127535D1 (de) | Vorbeugende oder therapeutische mittel gegen gastrische oder ösophageale regurgitation | |
| IL169257A0 (en) | Cycloalkene dicarboxylic acid compounds as anti-infammatory, immunomodulatory and anti-proliferatory agents | |
| NO20025035D0 (no) | Oksadiazolderivater som har anticancer-effekter | |
| DK132188D0 (da) | Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika | |
| DE60035429D1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
| EP1152004A4 (en) | PHOSPHONIC ACID DERIVATIVES HAVING CARBOXYPEPTIDASE B INHIBITOR ACTIVITY | |
| IL150965A0 (en) | Therapeutic or preventive agent for digestive system diseases containing a diaminotrifluoromethylpyridine derivative | |
| NO985202L (no) | Anti-heliobacter pylori-preparater inneholdende 1-metylcarbapenemderivater | |
| ATE293961T1 (de) | Verwendung von hydantoin und seinen derivaten gegen hypalbuminämie | |
| DK0556813T3 (da) | Amfotere tricykliske forbindelser som antihistaminske og antiallergiske midler | |
| AR040202A1 (es) | Combinacion de un agente inhibidor de la secrecion de acido y un inhibidor de reflujo para el tratamiento de la gerd | |
| PT1386608E (pt) | Agente terapêutico para doença glomerular | |
| WO2007000392A3 (en) | Chloro-substituted guanidines | |
| EP1393727A4 (en) | MEANS FOR THE TREATMENT OF MYELOPATHY |